NAMSW and NAMS Related Headlines
Go Back- NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
- NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma to Host R&D Day on June 11, 2025
NAMSW and NAMS Related Press Releases
Go Back- NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
- NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma to Host R&D Day on June 11, 2025

